Get insight from foundation experts on research, treatment and prevention, plus the very latest news and events.
Switch on your HIV smarts.
Given the advent of effective new treatments, hepatitis C was a major topic at the 20th International AIDS Conference held last week in Melbourne, Australia. An estimated 150 to 200 … Read More
The widely used antiretroviral drug efavirenz was not linked with neurocognitive impairment in a study reported this week at AIDS 2014. Efavirenz (Sustiva, also part of the popular Atripla combo … Read More
At AIDS 2014, underway this week in Melbourne, Australia, thousands of researchers, advocates, policymakers, and community members are gathered to learn the latest in HIV science and policy—and, importantly, to … Read More
Join us for daily news and commentary on HIV/AIDS treatment, prevention and policy.
The foundation's ongoing forum series bringing research and evidence to bear on timely policy and programmatic issues.